Recap: Alaunos Therapeutics Q3 Earnings

Alaunos Therapeutics TCRT reported its Q3 earnings results on Tuesday, November 14, 2023 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

Alaunos Therapeutics missed estimated earnings by 33.33%, reporting an EPS of $-0.04 versus an estimate of $-0.03.

Revenue was down $2.91 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 64.68% drop in the share price the next day.

To track all earnings releases for Alaunos Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

TCRT Logo
TCRTAlaunos Therapeutics Inc
$3.240.15%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
32.42
Growth
Not Available
Quality
Not Available
Value
1.80
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Comments
Loading...